Previous 10 | Next 10 |
Aethlon Medical (NASDAQ: AEMD ) -28% on pricing equity offering. More news on: Aethlon Medical, Inc., aTyr Pharma, Inc., DURECT Corporation, Stocks on the move, , Read more ...
Gainers: aTyr Pharma (NASDAQ: LIFE ) +48% . More news on: aTyr Pharma, Inc., Mechel PAO, The Habit Restaurants, Inc., Stocks on the move, Read more ...
These Penny Stocks Are Rallying Before The Open On Monday Welcome to Monday and a new week to make money with penny stocks . Over the weekend, more turmoil came about as the White House expanded its threat to the Middle East. The U.S. threatened to take out 52 Iranian sites if the country wer...
aTyr Pharma (NASDAQ: LIFE ) +63% on Kyorin Pharma deal . More news on: aTyr Pharma, Inc., Town Sports International Holdings, Inc., Pulmatrix, Inc., Stocks on the move, Read more ...
Thinly traded nano cap aTyr Pharma (NASDAQ: LIFE ) jumps 57% premarket on increased volume in reaction to its collaboration and license agreement with Kyorin Holdings ( OTC:KYRNF ) unit Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of lead candidate ...
aTyr eligible to receive up to $175 million in total payments, including $8 million upfront, plus tiered sales royalties Kyorin to fund all ATYR1923 development and commercialization activities in Japan SAN DIEGO, Jan. 06, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a...
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 11/13/2019. Please visit our Tracking Ole Andreas Halvorsen...
Gainers: Amneal Pharmaceuticals (NYSE: AMRX ) +49% . More news on: Amneal Pharmaceuticals, Inc., Diebold Nixdorf, Incorporated, Assembly Biosciences, Inc., Stocks on the move, Read more ...
CTI Industries (NASDAQ: CTIB ) -22% after signing Letter of Intent to Sell Mexican subsidiary, Flexo Universal. More news on: CTI Industries Corporation, DPW Holdings, Inc., Akoustis Technologies, Inc., Stocks on the move, Read more ...
Thinly traded nano cap aTyr Pharma (NASDAQ: LIFE ) is down 17% premarket on increased volume, 65K shares, in reaction to its announcement of safety and tolerability results from a multiple-ascending dose Phase 1b/2a clinical trial evaluating lead candidate ATYR1923 in pati...
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today ann...
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the c...
Independent data and safety monitoring board (DSMB) recommends continuation of study without any modifications. Findings further support favorable safety profile of efzofitimod. SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the “Compa...